Will details about lecture and consultant fees be included in exception clause?

When it comes to ‘lecture and consultant fees,’ positive atmosphere has been sensed. The issue was limitation of the pharmaceutical industry which have no choice but to depend on voluntary restriction for lecture and consultant fees.

According to multiple persons concerned in the pharmaceutical industry on the 14^th, the Korea Pharmaceutical Manufacturers Association(KPMA), the Korea Research-b...